Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Corrigendum: Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming.

Kwakkenbos MJ, Diehl SA, Yasuda E, Bakker AQ, van Geelen CM, Lukens MV, van Bleek GM, Widjojoatmodjo MN, Bogers WM, Mei H, Radbruch A, Scheeren FA, Spits H, Beaumont T.

Nat Med. 2016 Dec 6;22(12):1502. doi: 10.1038/nm1216-1502a. No abstract available.

PMID:
27923028
2.

Respiratory syncytial virus induced type I IFN production by pDC is regulated by RSV-infected airway epithelial cells, RSV-exposed monocytes and virus specific antibodies.

Schijf MA, Lukens MV, Kruijsen D, van Uden NO, Garssen J, Coenjaerts FE, Van't Land B, van Bleek GM.

PLoS One. 2013 Nov 26;8(11):e81695. doi: 10.1371/journal.pone.0081695. eCollection 2013.

3.

The comparative genomics of human respiratory syncytial virus subgroups A and B: genetic variability and molecular evolutionary dynamics.

Tan L, Coenjaerts FE, Houspie L, Viveen MC, van Bleek GM, Wiertz EJ, Martin DP, Lemey P.

J Virol. 2013 Jul;87(14):8213-26. doi: 10.1128/JVI.03278-12. Epub 2013 May 22.

4.

Intranasal administration of antibody-bound respiratory syncytial virus particles efficiently primes virus-specific immune responses in mice.

Kruijsen D, Einarsdottir HK, Schijf MA, Coenjaerts FE, van der Schoot EC, Vidarsson G, van Bleek GM.

J Virol. 2013 Jul;87(13):7550-7. doi: 10.1128/JVI.00493-13. Epub 2013 May 1.

5.

Genetic variability among complete human respiratory syncytial virus subgroup A genomes: bridging molecular evolutionary dynamics and epidemiology.

Tan L, Lemey P, Houspie L, Viveen MC, Jansen NJ, van Loon AM, Wiertz E, van Bleek GM, Martin DP, Coenjaerts FE.

PLoS One. 2012;7(12):e51439. doi: 10.1371/journal.pone.0051439. Epub 2012 Dec 7.

6.

Specific dietary oligosaccharides increase Th1 responses in a mouse respiratory syncytial virus infection model.

Schijf MA, Kruijsen D, Bastiaans J, Coenjaerts FE, Garssen J, van Bleek GM, van't Land B.

J Virol. 2012 Nov;86(21):11472-82. doi: 10.1128/JVI.06708-11. Epub 2012 Aug 15.

7.

Breastfeeding modulates neonatal innate immune responses: a prospective birth cohort study.

Belderbos ME, Houben ML, van Bleek GM, Schuijff L, van Uden NO, Bloemen-Carlier EM, Kimpen JL, Eijkemans MJ, Rovers M, Bont LJ.

Pediatr Allergy Immunol. 2012 Feb;23(1):65-74. doi: 10.1111/j.1399-3038.2011.01230.x. Epub 2011 Nov 22.

PMID:
22103307
8.

Low neonatal Toll-like receptor 4-mediated interleukin-10 production is associated with subsequent atopic dermatitis.

Belderbos ME, Knol EF, Houben ML, van Bleek GM, Wilbrink B, Kimpen JL, Rovers M, Bont L.

Clin Exp Allergy. 2012 Jan;42(1):66-75. doi: 10.1111/j.1365-2222.2011.03857.x. Epub 2011 Sep 20.

PMID:
22092594
9.

RSV 2010: Recent advances in research on respiratory syncytial virus and other pneumoviruses.

van Bleek GM, Osterhaus AD, de Swart RL.

Vaccine. 2011 Oct 6;29(43):7285-91. doi: 10.1016/j.vaccine.2011.07.114. Epub 2011 Aug 7.

PMID:
21827813
10.

Influencing mucosal homeostasis and immune responsiveness: the impact of nutrition and pharmaceuticals.

van't Land B, Schijf MA, Martin R, Garssen J, van Bleek GM.

Eur J Pharmacol. 2011 Sep;668 Suppl 1:S101-7. doi: 10.1016/j.ejphar.2011.05.082. Epub 2011 Jul 27. Review.

PMID:
21810416
11.

Local innate and adaptive immune responses regulate inflammatory cell influx into the lungs after vaccination with formalin inactivated RSV.

Kruijsen D, Schijf MA, Lukens MV, van Uden NO, Kimpen JL, Coenjaerts FE, van Bleek GM.

Vaccine. 2011 Mar 24;29(15):2730-41. doi: 10.1016/j.vaccine.2011.01.087. Epub 2011 Feb 19.

PMID:
21316502
12.

Serum antibodies critically affect virus-specific CD4+/CD8+ T cell balance during respiratory syncytial virus infections.

Kruijsen D, Bakkers MJ, van Uden NO, Viveen MC, van der Sluis TC, Kimpen JL, Leusen JH, Coenjaerts FE, van Bleek GM.

J Immunol. 2010 Dec 1;185(11):6489-98. doi: 10.4049/jimmunol.1002645. Epub 2010 Oct 22.

13.

Distinct abnormalities in the innate immune system of children with Down syndrome.

Bloemers BL, van Bleek GM, Kimpen JL, Bont L.

J Pediatr. 2010 May;156(5):804-9, 809.e1-809.e5. doi: 10.1016/j.jpeds.2009.12.006. Epub 2010 Feb 20.

PMID:
20172534
14.

The role of Toll-like receptors in regulating the immune response against respiratory syncytial virus.

Klein Klouwenberg P, Tan L, Werkman W, van Bleek GM, Coenjaerts F.

Crit Rev Immunol. 2009;29(6):531-50. Review.

PMID:
20121698
15.

Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming.

Kwakkenbos MJ, Diehl SA, Yasuda E, Bakker AQ, van Geelen CM, Lukens MV, van Bleek GM, Widjojoatmodjo MN, Bogers WM, Mei H, Radbruch A, Scheeren FA, Spits H, Beaumont T.

Nat Med. 2010 Jan;16(1):123-8. doi: 10.1038/nm.2071. Epub 2009 Dec 20. Erratum in: Nat Med. 2016 Dec 6;22(12 ):1502.

16.

A systemic neutrophil response precedes robust CD8(+) T-cell activation during natural respiratory syncytial virus infection in infants.

Lukens MV, van de Pol AC, Coenjaerts FE, Jansen NJ, Kamp VM, Kimpen JL, Rossen JW, Ulfman LH, Tacke CE, Viveen MC, Koenderman L, Wolfs TF, van Bleek GM.

J Virol. 2010 Mar;84(5):2374-83. doi: 10.1128/JVI.01807-09. Epub 2009 Dec 16.

17.

The association between intrauterine inflammation and spontaneous vaginal delivery at term: a cross-sectional study.

Houben ML, Nikkels PG, van Bleek GM, Visser GH, Rovers MM, Kessel H, de Waal WJ, Schuijff L, Evers A, Kimpen JL, Bont L.

PLoS One. 2009 Aug 10;4(8):e6572. doi: 10.1371/journal.pone.0006572.

18.

Skewed pattern of Toll-like receptor 4-mediated cytokine production in human neonatal blood: low LPS-induced IL-12p70 and high IL-10 persist throughout the first month of life.

Belderbos ME, van Bleek GM, Levy O, Blanken MO, Houben ML, Schuijff L, Kimpen JL, Bont L.

Clin Immunol. 2009 Nov;133(2):228-37. doi: 10.1016/j.clim.2009.07.003. Epub 2009 Aug 3.

19.

Respiratory syncytial virus-induced activation and migration of respiratory dendritic cells and subsequent antigen presentation in the lung-draining lymph node.

Lukens MV, Kruijsen D, Coenjaerts FE, Kimpen JL, van Bleek GM.

J Virol. 2009 Jul;83(14):7235-43. doi: 10.1128/JVI.00452-09. Epub 2009 May 6.

20.

Dynamics of human respiratory virus-specific CD8+ T cell responses in blood and airways during episodes of common cold.

Heidema J, Rossen JW, Lukens MV, Ketel MS, Scheltens E, Kranendonk ME, van Maren WW, van Loon AM, Otten HG, Kimpen JL, van Bleek GM.

J Immunol. 2008 Oct 15;181(8):5551-9.

21.

CD8+ T cell responses in bronchoalveolar lavage fluid and peripheral blood mononuclear cells of infants with severe primary respiratory syncytial virus infections.

Heidema J, Lukens MV, van Maren WW, van Dijk ME, Otten HG, van Vught AJ, van der Werff DB, van Gestel SJ, Semple MG, Smyth RL, Kimpen JL, van Bleek GM.

J Immunol. 2007 Dec 15;179(12):8410-7.

22.

Identification of a CD4 T cell epitope in the pneumonia virus of mice glycoprotein and characterization of its role in protective immunity.

Claassen EA, van Bleek GM, Rychnavska ZS, de Groot RJ, Hensen EJ, Tijhaar EJ, van Eden W, van der Most RG.

Virology. 2007 Nov 10;368(1):17-25. Epub 2007 Jul 16.

23.

Characterization of the CD8+ T cell responses directed against respiratory syncytial virus during primary and secondary infection in C57BL/6 mice.

Lukens MV, Claassen EA, de Graaff PM, van Dijk ME, Hoogerhout P, Toebes M, Schumacher TN, van der Most RG, Kimpen JL, van Bleek GM.

Virology. 2006 Aug 15;352(1):157-68. Epub 2006 May 30.

24.

Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines.

Niers LE, Timmerman HM, Rijkers GT, van Bleek GM, van Uden NO, Knol EF, Kapsenberg ML, Kimpen JL, Hoekstra MO.

Clin Exp Allergy. 2005 Nov;35(11):1481-9.

PMID:
16297146
25.

Activation and inactivation of antiviral CD8 T cell responses during murine pneumovirus infection.

Claassen EA, van der Kant PA, Rychnavska ZS, van Bleek GM, Easton AJ, van der Most RG.

J Immunol. 2005 Nov 15;175(10):6597-604.

26.

Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells.

de Graaff PM, de Jong EC, van Capel TM, van Dijk ME, Roholl PJ, Boes J, Luytjes W, Kimpen JL, van Bleek GM.

J Immunol. 2005 Nov 1;175(9):5904-11.

27.

Respiratory syncytial virus-specific CD8+ memory T cell responses in elderly persons.

de Bree GJ, Heidema J, van Leeuwen EM, van Bleek GM, Jonkers RE, Jansen HM, van Lier RA, Out TA.

J Infect Dis. 2005 May 15;191(10):1710-8. Epub 2005 Apr 11.

PMID:
15838799
28.

HLA-DP4 presents an immunodominant peptide from the RSV G protein to CD4 T cells.

de Graaff PM, Heidema J, Poelen MC, van Dijk ME, Lukens MV, van Gestel SP, Reinders J, Rozemuller E, Tilanus M, Hoogerhout P, van Els CA, van der Most RG, Kimpen JL, van Bleek GM.

Virology. 2004 Sep 1;326(2):220-30.

29.

Human CD8(+) T cell responses against five newly identified respiratory syncytial virus-derived epitopes.

Heidema J, de Bree GJ, De Graaff PM, van Maren WW, Hoogerhout P, Out TA, Kimpen JL, van Bleek GM.

J Gen Virol. 2004 Aug;85(Pt 8):2365-74.

PMID:
15269378
30.

Identification of immunodominant epitopes derived from the respiratory syncytial virus fusion protein that are recognized by human CD4 T cells.

van Bleek GM, Poelen MC, van der Most R, Brugghe HF, Timmermans HA, Boog CJ, Hoogerhout P, Otten HG, van Els CA.

J Virol. 2003 Jan;77(2):980-8.

31.

Isolation of an immunodominant viral peptide that is endogenously bound to the stress protein GP96/GRP94.

Nieland TJ, Tan MC, Monne-van Muijen M, Koning F, Kruisbeek AM, van Bleek GM.

Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):6135-9.

32.

The role of self peptides in the allogeneic cross-reactivity of CTLs.

Kuzushima K, Sun R, van Bleek GM, Vegh Z, Nathenson SG.

J Immunol. 1995 Jul 15;155(2):594-601.

PMID:
7541821
33.

Diversity of T cell receptors specific for the VSV antigenic peptide (N52-59) bound by the H-2Kb class I molecule.

Imarai M, Goyarts EC, van Bleek GM, Nathenson SG.

Cell Immunol. 1995 May;162(2):340. No abstract available.

PMID:
7743562
34.

Diversity of T cell receptors specific for the VSV antigenic peptide (N52-59) bound by the H-2Kb class I molecule.

Imarai M, Goyarts EC, van Bleek GM, Nathenson SG.

Cell Immunol. 1995 Jan;160(1):33-42. Erratum in: Cell Immunol. 1995 May;162(2):340.

PMID:
7842484
35.
36.

Peptide presentation by major histocompatibility class I molecules.

van Bleek GM, Nathenson SG.

Chem Immunol. 1993;57:1-17. Review. No abstract available.

PMID:
8260084
37.

Presentation of antigenic peptides by MHC class I molecules.

van Bleek GM, Nathenson SG.

Trends Cell Biol. 1992 Jul;2(7):202-7.

PMID:
14731501
38.

Synthetic peptide libraries in the determination of T cell epitopes and peptide binding specificity of class I molecules.

Schumacher TN, Van Bleek GM, Heemels MT, Deres K, Li KW, Imarai M, Vernie LN, Nathenson SG, Ploegh HL.

Eur J Immunol. 1992 Jun;22(6):1405-12.

PMID:
1376257
41.

Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule.

Van Bleek GM, Nathenson SG.

Nature. 1990 Nov 15;348(6298):213-6.

PMID:
1700303

Supplemental Content

Loading ...
Support Center